• News
  • SAN DIEGO
  • BioTech

Dexcom, Asante Solutions agree to data integration

San Diego-based DexCom Inc. (Nasdaq: DXCM) and Asante Solutions Inc., manufacturer of the Asante Snap Insulin Pump, announced Thursday their intention to enable the Dexcom mobile app platform, which is currently under development, to integrate and display insulin data from the Asante Snap Insulin Pump.

This will be the second insulin delivery device to be integrated into the Dexcom mobile app, which is designed to aggregate glucose and other diabetes-related data from patients’ devices and display the integrated data on a smartphone.

In June, Dexcom announced its intention to maintain an “open architecture” approach to diabetes-related data that will include an “Authorized by Dexcom” mark to indicate the compatibility of devices and apps integrating Dexcom CGM data.

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

Dexcom Inc.

Company Website

5555 Oberlin Dr.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
DXCM
83.28
  -1.07  
- 1.27%
2,134,944,000
103.29
40.39

Insider Trade Data

Date Insider Shares Type Value
10/20/2015 Balo, Andrew K 4,538 Sell $369,670
10/19/2015 Roper, Jess 7,000 Sell $583,573
10/19/2015 Roper, Jess 6,000 Exchange $58,800
10/15/2015 Gregg, Terrance H 15,000 Sell $1,168,796
10/08/2015 Lister, John 2,750 Sell $211,748

Dexcom Inc. Executive(s):

Terrance Gregg

  • Chief Executive Officer, Director

Kevin Sayer

  • Director, President

Patrick Murphy

  • Assist. General Counsel